Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Irvine at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
This study will evaluate the safety and efficacy of intravesical administration of EG-70 in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phases; a Phase 1 dose-escalation to establish safety and recommended the phase 2 dose, followed by a Phase 2 study to establish how effective the treatment is. The Study will include patients with NMIBC with Cis for whom BCG therapy is unresponsive and patients with NMIBC with Cis who are BCG-naïve or
Sponsor: enGene, Inc.
Check if you qualify for this bladder cancer clinical trial in Irvine, CA
If you're searching for bladder cancer treatment options in Irvine, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.